Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells

Journal of Clinical Investigation

Volumn 98, Issue 7, 1996, Pages 1659-1666

  Fais, Franco ^a   Sellars, Brian ^a   Ghiotto, Fabio ^a   Yan, Xiao Jie ^a   Dono, Mariella ^c   Allen, Steven L ^a   Budman, Daniel ^a   Dittmar, Klaus ^a   Kolitz, Jonathan ^a   Lichtman, Stuart M ^a   Schulman, Philip ^a   Schuster, Michael ^a   Vinciguerra, Vincent P ^a   Rai, Kanti ^d   Stevenson, Freda K ^b   Gregersen, Peter K ^a   Ferrarini, Manlio ^c   Chiorazzi, Nicholas ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

^d LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

autoantibodies; autoimmune hemolytic anemia; immunoglobulin variable region; point mutation; surface immunoglobulins

Indexed keywords

CD5 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN PRODUCTION; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 10144259343     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118961     Document Type: Article

References (49)

1. Dighiero, G., P. Travade, S. Chevret, P. Fenaux, C. Chastang, and J.L. Binet. 1991. B-cell chronic lymphocytic leukemia: present status and future directions. Blood. 78:1901-1914.
2. Fu, S.M., N. Chiorazzi, H.G. Kunkel, J.P. Halper, and S. Harris. 1978. Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J. Exp. Med. 148:1570-1578.
3. Totterman, T.H., N. Nilsson, and C. Sundstrom. 1980. Phorbol ester-induced differentiation of chronic lymphocytic leukemia cells. Nature (Lond.). 288:176-178.
4. Julliusson, G., K.-H. Rober, I., Hammarstrom, C.I.E. Smith, G. Biberfeld, and G. Gahrton. 1983. Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukemia and immunocytoma cell populations. Scand. J. Immunol. 17:51-59.
5. Sarfati, M., H. Luo, and G. Delespesse. 1989. IgE synthesis by chronic lymphocytic leukemia cells. J. Exp. Med. 170:1755-1780.
6. Fu, S.M., R.J. Winchester, T. Feizi, P.D. Walzer, and H.G. Kunkel. 1974. Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow derived lymphocytes. Proc. Natl. Acad. Sci. USA. 71:4487-1490.
7. Deegan, M.J., J.P. Abraham, M. Sawdyk, and E.J. Van Slyck. 1984. High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients. Blood. 64:1207-1211.
8. Miller, R.H., M.S. Linet, M.I., Van Natta, L.D. McCaffery, and R.L. Humphrey. 1987. Serum protein electrophoresis patterns in chronic lymphocytic leukemia. Arch. Intern. Med. 147:1614-1617.
9. Pangalis, G.A., N.M. Papadopoulos, and H.A. Moutsopoulos, 1987. Paraproteins in the serum of B-chronic lymphocytic leukemia. In Chronic Lymphocytic Leukemia: Recent Progress and Future Direction. R.P. Gale and K. Rai, editors. Alan R. Liss, Inc., New York. 245-252.
10. Kubagawa, H., L.B. Vogler, J.D. Capra, M.F. Conrad, A.R. Lawton, and M.D. Cooper. 1979. Studies on the clonal origin of multiple myeloma: Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B cell differentiation. J. Exp. Med. 150:792-807.
11. Grogan, T.M., B.G. Durie, C. Lomen, C. Spier, D.P. Wirtz, R. Nagle, G.S. Wilson, L. Richter, I., Vela, V. Maxey, K. McDaniel, and C. Rangel. 1987. Delineation of a novel pre-B cell compartment in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture and kinetic features. Blood. 70:932-942.
12. Jensen, G.S., M.J. Mant, and L.M. Pilarski. 1992. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node and bone marrow from a terminal myeloma patient. Am. J. Hematol. 41:199-208.
13. Billadeau, D., G. Ahmann, P. Greipp, and B. Van Ness, 1993. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med. 178:1023-1031.
14. Corradini, P., M. Boccadoro, C. Voena, and A. Pileri. 1993. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (Ig)G- and IgA-secreting multiple myelomas. J. Exp. Med. 178:1091-1096.
15. Bertoli, L.F., H. Kubagawa, G.V. Borzillo, P.D. Burrows, M.T. Schreeder, A.J. Carrol, and M.D. Cooper. 1988. Bone marrow origin of a B-cell lymphoma. Blood. 72:94-101.
16. Jain, R., S. Roncella, S. Hashimoto, A. Carbone, P. Francia di Celle, R. Foa, M. Ferrarini, and N. Chiorazzi. 1994. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J. Immunol. 153:45-52.
17. Richter, M.N. 1982. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am. J. Pathol. 4:285-292.
18. Harousseau, J.L., G. Flandrin, G. Tricot, J.C. Brouet, M. Seligmann, and J. Bernard. 1981. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 21 cases. Cancer. 48:1302-1308.
19. Sun, T., M. Susin, M. Desner, R. Pergolizzi, J. Cuomo, and P. Koduru. 1990. The clonal origin of two cell populations in Richter's syndrome. Hum. Pathol. 21:722-728.
20. Mayumi, M., H. Kubagawa, G.A. Omura, W.E. Gathings, J.F. Kearney, and M.D. Cooper. 1982. Studies on the clonal origin of human B cell leukemia using monoclonal anti-idiotype antibodies. J. Immunol. 129:904-910.
21. Vogler, L.B., J.L. Preud'homme, M. Seligmann, W.E. Gathing, W.M. Crist, M.D. Cooper, and F.J. Bollum. 1981. Diversity of immunoglobulin expression in leukemic cells resembling B lymphocyte precursors. Nature (Lond.), 290:339-341.
22. Dono, M., S. Hashimoto, F. Fais, V. Trejo, S.L. Allen, S.M. Lichtman, P. Schulman, V.P. Vinciguerra, B. Sellars, P.K. Gregersen, M. Ferrarini, and N. Chiorazzi. 1996. Evidence for progenitors of B-CLL cells that undergo intraclonal differentiation and diversification. Blood. 87:1586-1594.
23. Silverman, G.J., M. Sasano, and S.B. Wormsley. 1993. Age-associated changes in binding of human B lymphocytes to a VH3 restricted unconventional bacterial antigen. J. Immunol. 151:5840-5855.
24. Stevenson, F.K., M. Wrightham, M.J. Glennie, D.B. Jones, A.R. Cattan, T. Feizi, T.J. Hamblin, and G.T. Stevenson. 1986. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 68: 430-436.
25. Rai, K.R., A. Sawitsky, E.P. Cronkite, A.D. Chanana, R.N. Levy, and B.S. Pasternack. 1975. Clinical staging of chronic lymphocytic leukemia. Blood. 46:219-234.
26. Shin, E.K., F. Matsuda, H. Nagaoka, Y. Fukita, T. Imai, K. Yokoyama, H. Soeda, and T. Homo. 1991. Physical map of the 3′ region of the human immunoglobulin heavy chain locus: clustering of autoantibody-related variable segments in one haplotype. EMBO (Eur. Mol. Biol. Organ.) J. 10:3641-3545.
27. Deane, M. and J.D. Norton. 1991. Immunoglobulin gene "fingerprinting": an approach to analysis of B lymphocyte clonality in lymphoproliferative disorders. Br. J. Haematol. 77:274-281.
28. + human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Autoimmunity, 19:39-48.
29. Mestecky, J., R.J. Winchester, T. Hoffman, and H.G. Kunkel. 1977. Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines. J. Exp. Med. 145:760-765.
30. Mestecky, J., and J.R. McGhee. 1987. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
31. MacLennan, I.C., Y.J. Liu, S. Oldfield, J. Zhang, and P.J. Lane. 1990. The evolution of B-cell clones. Curr. Top. Microbiol. Immunol. 159:37-63.
32. Broker, B.M., A. Klajman, P. Youinou, J. Jouquan, C.P. Worman, J. Murphy, L. Mackenzie, R. Quartey-Papafio, M. Blaschek, P. Collins, S. Lai, and P.M. Lydyard. 1988. Chronic lymphocytic leukemia cells secrete multispecific antibodies. J. Autoimmunity. 1:469-481.
33. Sthoeger, Z.M., M. Wakai, D.B. Tse, V.P. Vinciguerra, S.L. Allen, D.R. Budman, S.M. Lichtman, P. Schulman, L.R. Weiselberg, and N. Chiorazzi. 1989. Production of autoantibudies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J. Exp. Med. 169:255-268.
34. Borche, L., A. Lim, J.-L. Binet, and G. Dighiero. 1990. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood. 76:562-569.
35. Kipps, T.J., and D.A. Carson. 1993. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood. 81:2475-2487.
36. Kipps, T.J., E. Tomhave, P.P. Chen, and D.A. Carson. 1988. Autoantibody associated κ light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy. J. Exp. Med. 167:840-852.
37. Meeker, T.C., J.C. Grimaldi, R. O'Rourke, J. Loeb, G. Juliusson, and S. Einhorn. 1988. Lack of detectable somatic hypermutation in the V region of the Ig H chain gene of a human chronic B lymphocytic leukemia.J. Immunol. 141: 3994-3998.
38. H5 genes used in common B cell chronic lymphocytic leukemia. J. Exp. Med. 177:1039-1046.
39. Kipps, T. 1993. Immunoglobulin genes in chronic lymphocytic leukemia. Blood. Cells. 19:615-625.
40. Friedman, D.F., J.S. Moore, J. Erikson, J. Manz, J. Goldman, P.C. Nowell, and L.E. Silberstein. 1992. Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia. Blood. 80:2287-2297.
41. I regions expressed in IgG-bearing chronic lymphocytic leukemia (CLL): further evidence that CLL is a heterogenous group of tumors. Blood. 82:1623-1626.
42. + chronic lymphocytic leukemia B cells. J. Exp. Med. 181:1507-1517.
43. Engelfreit, C.P., M.A.M. Overbeeke, and A.E.G.Kr. von dem Borne. 1992. Autoimmune hemolytic anemia. Semin. Hematol. 29:3-12.
44. Litwin, S.D., S. Balaban, and M.E. Eyster. 1973. Gm allotype preference in erythrocyte IgG antibodies of patients with autoimmune hemolytic anemia. Blood. 42:241-246.
45. Leddy, J.P., and R.F. Bakemeier. 1965. Structural aspects of human erythrocyte autoantibodies. I. L chain types and electrophoretic dispersion. J. Exp. Med. 121:1-17.
46. Sthoeger, Z.M., D. Sthoeger, M. Shtairid, E. Sigler, D. Geltner, and A. Berrebi. 1993. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Ant. J. Hematol. 43:259-264.
47. Andrzejewski, C., Jr., P.J. Young, D.B. Cines, and L.E. Silberstein. 1990. Heterogeneity of human red cell autoantibodies assessed by isoelectric focusing. Transfusion. 31:236-244.
48. + (CD5) B cells that recognize phosphatidyl choline: relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 168:687-698.
49. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S.-I. Kumagai, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175:71-79.